<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>

        References<lb/> 
        <bibl><label>1</label>. Compendium of Health Statistics. London:<lb/> Office of Health Economics, 1992: section<lb/> 4:38.<lb/> </bibl>
        <bibl><label>2</label>. Quick JM, Blenkinsopp A. A community<lb/> pharmacy study to compare the control of hay<lb/> fever symptoms by astemizole lOmg and<lb/> terfenadine 120mg. Pharm J 1991;246:272-5.<lb/> </bibl>
        <bibl><label>3</label>. Kaiser HB. H,-receptor antagonist treatment<lb/> of seasonal allergic rhinitis. J Allergy Clin<lb/> Immunol 1990;86:1000-3.<lb/> </bibl>
        <bibl><label>4</label>. Beswick KBJ, Kenyon GS, Cherry JR. A<lb/> comparative study of beclomethasone<lb/> dipropionate aqueous nasal spray with<lb/> terfenadine tablets in seasonal allergic rhinitis.<lb/> Curr Med Res Opin 1985;9:560-7.<lb/> </bibl>
        <bibl><label>5</label>. Flolund L. Efficacy of an oral antihistamine,<lb/> loratadine, as compared with a nasal steroid<lb/> spray, beclomethasone dipropionate, in<lb/> seasonal allergic rhinitis. Clin Otolaryngol<lb/> </bibl>
        <bibl><label>6</label>. Blenkinsopp A, Bradley C. Patients, society,<lb/> and the increase in self medication. BMJ<lb/> </bibl>
        <bibl><label>7</label>. Nathan A. A non-prescription formulary.<lb/> Hay fever treatments. Pharm J 1996;256:188-<lb/>91.<lb/> </bibl>
        <bibl><label>8</label>. Dean AD, Dean JA, Burton JH, Dicker RC.<lb/> Epi-info Version 5. A data processing, database<lb/> and statistics programme for epidemiology on<lb/> microcomputers. Atlanta, Georgia: Centers for<lb/> Disease Control, 1990.<lb/> </bibl>
        <bibl><label>9</label>. Grewar J, Matthews J, McMahon A D,<lb/> MacDonald T M. Capturing data on over-the-<lb/>counter medicines in community pharmacies: a<lb/> methodological study. Pharm J 1997;<lb/> </bibl>
        <bibl><label>10</label>. Elliot J. Getting a good response . . . the<lb/> importance of response rates in survey<lb/> research. Research Bulletin 5.1. Manchester:<lb/> Pharmacy Practice Research Resource Centre,<lb/> 1996.<lb/> </bibl>
        <bibl><label>11</label>. Allergy News. Issue 11. London: British<lb/> Allergy Foundation, 199.56-8.<lb/> </bibl>
        <bibl><label>12</label>. Guidelines for OTC treatment of hay fever.<lb/> British Society for Allergy and Clinical<lb/> Immunology, 1996.<lb/> </bibl>
        <bibl><label>13</label>. Thomas DHV, Noyce PR. The interface<lb/> between self medication and the NHS. BMJ<lb/> </bibl>
        <bibl><label>14</label>. Schafheutle E L. Deregulation of POM:<lb/> decision-making and outcomes in patients<lb/> treating a minor ailment [MSc dissertation].<lb/> </bibl>
<bibl>Manchester: University of Manchester, 1994.<lb/> 1991;16:527-31.<lb/> 1996;3 12:629-32.<lb/> 259:736-9.<lb/> 1996;3 12:688-90.<lb/> </bibl>
        <bibl><label>1</label>. Which of the following age groups applies to you? 18-<lb/>34 I 35-55 I Over 55</bibl>
        </listBibl>
    </text>
</tei>

